HSIL Limited [HSIL] vs Fischer Medical [FISCHER] Detailed Stock Comparison
HSIL Limited
NSE
Loading...
Fischer Medical
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: HSIL Limited wins in 7 metrics, Fischer Medical wins in 4 metrics, with 0 ties. HSIL Limited appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | HSIL Limited | Fischer Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 18.70 | 5,097.11 | HSIL Limited |
| Price-to-Book Ratio | N/A | 32.00 | N/A |
| Debt-to-Equity Ratio | 89.90 | 25.27 | Fischer Medical |
| EV/EBITDA | 20.08 | 2,754.24 | HSIL Limited |
| Profit Margin (TTM) | 72.43% | 1.31% | HSIL Limited |
| Operating Margin (TTM) | N/A | 4.05% | N/A |
| EBITDA Margin (TTM) | N/A | 4.05% | N/A |
| Return on Equity | 1,493.74% | 0.57% | HSIL Limited |
| Return on Assets (TTM) | 7.66% | 0.73% | HSIL Limited |
| Free Cash Flow (TTM) | N/A | $-922.39M | N/A |
| 1-Year Return | 21.01% | 50.52% | Fischer Medical |
| Price-to-Sales Ratio (TTM) | 3.75 | 55.98 | HSIL Limited |
| Enterprise Value | $64.93B | $105.60B | Fischer Medical |
| EV/Revenue Ratio | 4.54 | 94.12 | HSIL Limited |
| Gross Profit Margin (TTM) | -49.38% | 20.06% | Fischer Medical |
| Revenue per Share (TTM) | N/A | $17 | N/A |
| Earnings per Share (Diluted) | N/A | $0.19 | N/A |
| Beta (Stock Volatility) | N/A | -0.02 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
HSIL Limited vs Fischer Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| HSIL Limited | 0.05% | -2.86% | 17.77% | 16.69% | 28.68% | -16.97% |
| Fischer Medical | -0.03% | 0.59% | 21.01% | 27.48% | 35.46% | 36.48% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| HSIL Limited | 21.01% | 202.58% | 1,446.76% | 1,043.43% | 2,460.71% | 5,406.29% |
| Fischer Medical | 50.52% | 2,061.35% | 2,131.55% | 1,379.69% | 10,586.67% | 10,879.45% |
Performance & Financial Health Analysis: HSIL Limited vs Fischer Medical
| Metric | HSIL | FISCHER |
|---|---|---|
| Market Information | ||
| Market Cap | ₹53.70B | ₹62.81B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 57,776 | 3,303 |
| 90 Day Avg. Volume | 89,766 | 13,029 |
| Last Close | ₹920.00 | ₹961.55 |
| 52 Week Range | ₹599.10 - ₹1,307.90 | ₹573.60 - ₹1,000.00 |
| % from 52W High | -29.66% | -3.85% |
| All-Time High | ₹1,307.90 (Dec 16, 2024) | ₹2,386.00 (Apr 21, 2008) |
| % from All-Time High | -29.66% | -59.70% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -1.27% | 1.37% |
| Quarterly Earnings Growth | N/A | -0.35% |
| Financial Health | ||
| Profit Margin (TTM) | 0.72% | 0.01% |
| Operating Margin (TTM) | N/A | 0.04% |
| Return on Equity (TTM) | 14.94% | 0.01% |
| Debt to Equity (MRQ) | 89.90 | 25.27 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | N/A | ₹30.27 |
| Cash per Share (MRQ) | N/A | ₹22.54 |
| Operating Cash Flow (TTM) | ₹686.00M | ₹-862,518,016 |
| Levered Free Cash Flow (TTM) | ₹1.93B | ₹-547,108,480 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: HSIL Limited vs Fischer Medical
| Metric | HSIL | FISCHER |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 18.70 | 5,097.11 |
| Forward P/E | 15.71 | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 3.75 | 55.98 |
| Price to Book (MRQ) | N/A | 32.00 |
| Market Capitalization | ||
| Market Capitalization | ₹53.70B | ₹62.81B |
| Enterprise Value | ₹64.93B | ₹105.60B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.54 | 94.12 |
| Enterprise to EBITDA | 20.08 | 2,754.24 |
| Risk & Other Metrics | ||
| Beta | N/A | -0.02 |
| Book Value per Share (MRQ) | N/A | ₹30.27 |
Financial Statements Comparison: HSIL Limited vs Fischer Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HSIL | FISCHER |
|---|---|---|
| Revenue/Sales | N/A | ₹491.74M |
| Cost of Goods Sold | N/A | ₹393.11M |
| Gross Profit | N/A | ₹98.64M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | ₹19.93M |
| EBITDA | N/A | ₹25.49M |
| Pre-Tax Income | N/A | ₹18.12M |
| Income Tax | N/A | ₹5.00M |
| Net Income (Profit) | N/A | ₹13.12M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HSIL | FISCHER |
|---|---|---|
| Cash & Equivalents | N/A | ₹1.04B |
| Total Current Assets | N/A | ₹3.65B |
| Total Current Liabilities | N/A | ₹815.68M |
| Long-Term Debt | N/A | ₹374.59M |
| Total Shareholders Equity | N/A | ₹3.38B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | N/A | ₹186.04M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HSIL | FISCHER |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HSIL | FISCHER |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 57,776 | 3,303 |
| Average Daily Volume (90 Day) | 89,766 | 13,029 |
| Shares Outstanding | 64.70M | 63.80M |
| Float Shares | N/A | 25.71M |
| % Held by Insiders | N/A | 0.79% |
| % Held by Institutions | N/A | 0.03% |
Dividend Analysis & Yield Comparison: HSIL Limited vs Fischer Medical
| Metric | HSIL | FISCHER |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |